Monday, September 14, 2026

Brand Strategy for Economic Resilience: Win Over 1% for Success, Experts Advise

To thrive in retail, brands must build a loyal 1% customer base and a strong brand identity, especially during economic downturns.

IMMEDIATE COLLECTIVE ACTION: Seoul, Washington, And Tokyo Unite To Confront Pyongyang’s Escalating Threat

The U.S., South Korea, and Japan condemn North Korea's missile launch as a violation of UN sanctions, reaffirming their commitment to regional security.

Fired Navy Commander Seen in Kim Jong Un Documentary Despite Ship Mishap

Kim Myong Sik reappears in North Korean media after a destroyer launch failure, raising concerns about leadership changes and potential punishments.

Tag: Yuflyma

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Top News

- Our Sponsors Ad -

Follow us